Investment Thesis
Despite strong 24.5% revenue growth and 99.6% net income improvement, BRCB faces critical cash flow deterioration with -$9.4M free cash flow and liquidity ratios below 1.0, indicating potential short-term financial stress. The company is burning cash while funding aggressive capex, unsustainable for a thin-margin retail food business.
Strengths
- Strong revenue growth of 24.5% YoY showing market demand
- Net income nearly doubled YoY (+99.6%) from improved operations
- Positive operating cash flow of $6.8M provides some financial cushion
Risks
- Negative free cash flow of -$9.4M despite revenue growth indicates value destruction
- Current ratio of 0.87x and quick ratio of 0.77x signal imminent liquidity crisis
- Net margin of only 0.7% leaves minimal buffer for operational challenges or market downturns
- Capital expenditure of $16.2M significantly exceeds operating cash generation, requiring external financing
- Poor returns on equity (0.8%) and assets (0.1%) despite substantial $347.2M asset base
- Missing gross margin data and interest coverage ratio raise data quality concerns
Key Metrics to Watch
- Free cash flow trajectory and path to cash flow break-even
- Current and quick ratio improvement to above 1.0
- Gross profit margin trends and operating leverage
- Capital expenditure levels relative to operating cash flow sustainability
Financial Metrics
Revenue
55.5M
Net Income
378.0K
EPS (Diluted)
$0.02
Free Cash Flow
-9.4M
Total Assets
347.2M
Cash
20.0M
Profitability Ratios
Gross Margin
N/A
Operating Margin
4.8%
Net Margin
0.7%
ROE
0.8%
ROA
0.1%
FCF Margin
-17.0%
Balance Sheet & Liquidity
Current Ratio
0.87x
Quick Ratio
0.77x
Debt/Equity
0.60x
Debt/Assets
69.0%
Interest Coverage
N/A
Long-term Debt
28.5M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-14T08:02:49.274749 |
Data as of: 2026-03-31 |
Powered by Claude AI